The new survivors and a new era for trauma research

PLoS Medicine

Volumn 14, Issue 7, 2017, Pages

  Brohi, Karim ^a   Schreiber, Martin ^b  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOVASCULAR DISEASE; EDITORIAL; HUMAN; INJURY; MALIGNANT NEOPLASM; PHENOTYPE; RESUSCITATION; SURVIVOR; PATHOPHYSIOLOGY; RESEARCH; TRENDS; WOUNDS AND INJURIES;

HUMANS; RESEARCH; SURVIVORS; WOUNDS AND INJURIES;

EID: 85026680302     PISSN: 15491277     EISSN: 15491676     Source Type: Journal    
DOI: 10.1371/journal.pmed.1002354     Document Type: Editorial

References (7)

1. Hauser CJ, Boffard K, Dutton R, Bernard GR, Croce MA, Holcomb JB, CONTROL Study Groupet al. Results of the CONTROL trial: efficacy and safety of recombinant activated Factor VII in the management of refractory traumatic hemorrhage. J Trauma. 2010;69:489–500. doi: 10.1097/TA.0b013e3181edf36e 20838118.
2. Holcomb JB, Major scientific lessons learned in the trauma field over the last two decades. PLoS Med. 2017Jul.
3. Resuscitation Outcomes Consortium. https://roc.uwctc.org/. Accessed: 31 May 2017.
4. International Trauma Research Network. http://www.intrn.org. Accessed: 31 May 2017.
5. Inflammation and the Host Response to Injury. http://www.gluegrant.org. Accessed 31 May 2017.
6. Hess JR, Brohi K, Dutton RP, Hauser CJ, Holcomb JB, Kluger Y, et al. The coagulopathy of trauma: a review of mechanisms. J Trauma. 2008Oct;65(4):748–54. doi: 10.1097/TA.0b013e3181877a9c 18849786.
7. Holcomb JB, Jenkins D, Rhee P, Johannigman J, Mahoney P, Mehta S, et al. Damage control resuscitation: directly addressing the early coagulopathy of trauma. J Trauma. 2007;62:307–10. doi: 10.1097/TA.0b013e3180324124 17297317.